Radnostix, Inc. (INIS)
$0.05+0.00%Close
SELLCRISIS · day 5
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $26M
- Beta
- 1.29
- P/E (TTM)
- -0.00
- Short % float
- 0.00%
- Days to cover
- 1.0
- SI change
- -84.5%
- 1W
- -16.67%
- 1M
- -16.67%
- vs SPY 1W
- -16.53%
- vs SPY 1M
- -19.17%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 0
- GROWTH
- 12
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-
REV YoY-
ROE-
EPS YoY-
ROA-
GROSS32
OP-26
NET-8087807
[VALUATION]
P/E TTM-0.00
P/E FWD-
SECTOR PE20.34
INDUSTRY PE19.31
P/B13.65
P/FCF-
EV/EBITDA-15.73
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E486.77
ALTMAN Z-
CURR RATIO0.84
ND/EBITDA-
BETA1.29
Company news
FAQ
- What is LOPJLB’s current signal on INIS?
- LOPJLB’s latest quantitative signal on Radnostix, Inc. (INIS) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is INIS in?
- Radnostix, Inc. (INIS) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Radnostix, Inc. (INIS) do?
- Radnostix, Inc. (INIS) is a company that specializes in the global manufacturing and sale of crucial nuclear medicine calibration and reference standards, cobalt-60 products, and offers contract services for producing radiopharmaceuticals and radiochemicals. Its operations are structured into five key divisions: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Radiological S…